Cargando…
Replacing the Rhamnose‐Xylose Moiety of QS‐21 with Simpler Terminal Disaccharide Units Attenuates Adjuvant Activity in Truncated Saponin Variants
Adjuvants are key immunostimulatory components in vaccine formulations, which improve the immune response to the co‐administered antigen. The saponin natural product QS‐21 is one of the most promising immunoadjuvants in the development of vaccines against cancer and infectious diseases but suffers f...
Autores principales: | Fuentes, Roberto, Ruiz‐de‐Angulo, Ane, Sacristán, Nagore, Navo, Claudio Daniel, Jiménez‐Osés, Gonzalo, Anguita, Juan, Fernández‐Tejada, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986102/ https://www.ncbi.nlm.nih.gov/pubmed/33236801 http://dx.doi.org/10.1002/chem.202004705 |
Ejemplares similares
-
Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants
por: Fuentes, Roberto, et al.
Publicado: (2022) -
Development of synthetic, self-adjuvanting, and self-assembling anticancer vaccines based on a minimal saponin adjuvant and the tumor-associated MUC1 antigen
por: Pifferi, Carlo, et al.
Publicado: (2023) -
Design, synthesis, and initial immunological evaluation of glycoconjugates based on saponin adjuvants and the Tn antigen
por: Fuentes, Roberto, et al.
Publicado: (2021) -
The Disaccharide
Moiety of Bleomycin Facilitates Uptake
by Cancer Cells
por: Schroeder, Benjamin R., et al.
Publicado: (2014) -
Development of a minimal saponin vaccine adjuvant based on QS-21
por: Fernández-Tejada, Alberto, et al.
Publicado: (2014)